This site demonstrates one possible use of this domain. For acquisition, partnership, or investment inquiries, please use our contact link.
Ketalux
Neuroscience

How Ketamine Works in the Brain

A careful look at the leading scientific explanations for ketamine's effects on mood — written for non-specialists, grounded in published research.

Medically reviewed by: Pending medical review(draft)Last updated: May 18, 2026Evidence: Neuroscience review
Watch · 5s

Glutamate signaling and the plasticity window

A short, abstract visualization of synaptic signaling — the kind of activity researchers believe ketamine briefly amplifies.

From this video
What is the 'plasticity window'?+

A short, transient period of enhanced synaptic plasticity that follows a subanesthetic dose of ketamine in animal and human studies — believed to be when the brain is most receptive to forming new connections.

Does this video show a real brain scan?+

No. It is an abstract visualization, not a clinical image. The science is summarized in the transcript and the article below.

Ketamine is a dissociative anesthetic developed in the 1960s. At anesthetic doses it is used in surgery and emergency medicine. At much lower (subanesthetic) doses, it is studied for its rapid effects on mood, especially in treatment-resistant depression.

How it affects the brain

Ketamine binds to NMDA receptors — a subtype of glutamate receptor central to learning and memory. By temporarily blocking these receptors on certain inhibitory neurons, ketamine increases glutamate release. This downstream surge activates AMPA receptors and engages intracellular pathways (notably BDNF and mTOR signaling) associated with synaptic growth.

Presynaptic neuronPostsynaptic neuronSYNAPTIC CLEFTGlutamateNMDA receptorAMPA receptor
Stylized synapse. Glutamate released from the presynaptic terminal binds NMDA and AMPA receptors on the postsynaptic neuron.
  1. Step 1
    NMDA blockade
    on inhibitory neurons
  2. Step 2
    Glutamate surge
    into the synapse
  3. Step 3
    AMPA activation
    downstream signaling
  4. Step 4
    BDNF + mTOR
    intracellular pathways
  5. Step 5
    Synaptic growth
    transient plasticity
Leading mechanistic hypothesis for ketamine's rapid antidepressant effects.
Stylized depiction of network-level signaling — not a clinical diagram

Glutamate and neuroplasticity, explained simply

Glutamate is the brain's most abundant excitatory neurotransmitter. Many researchers believe depression is associated with weakened or impaired synaptic connections in regions like the prefrontal cortex. Ketamine appears to briefly strengthen synaptic signaling and promote the growth of new dendritic spines in animal models — a phenomenon often summarized under the umbrella term neuroplasticity.

Why this differs from SSRIs

  • Target system: SSRIs modulate serotonin; ketamine primarily acts on glutamate.
  • Timeline: SSRIs typically take weeks; ketamine effects can emerge within hours.
  • Mechanism of change: SSRIs gradually shift neurochemistry; ketamine appears to influence plasticity directly.
  • Durability: SSRI benefits build over time; ketamine effects are often time-limited without repeated dosing and integrated care.
KetamineEffects may emerge within hours
SSRIsTypically 4–8 weeks to clinical effect
Hours1 day1 week2 weeks4 weeks8 weeks
Illustrative timelines. Individual response varies; not a clinical prediction.

What patients may experience

During a supervised session, people commonly report dissociation, altered perception, emotional intensity, and a sense of distance from ordinary thinking. Effects usually subside within an hour or two. Reactions are highly individual and depend on dose, setting, history, and protocol.

The role of integration and therapy

Many clinicians argue that the neurobiological window opened by ketamine is most useful when paired with structured psychological support — sometimes called integration — so that insights and emotional material can be processed in a sustained way.

Frequently asked questions

How quickly does ketamine work?+

In clinical studies, some patients with treatment-resistant depression report symptom reductions within hours to days of a supervised dose. Durability of effect typically requires repeated dosing and broader care.

Is ketamine a psychedelic?+

Ketamine is a dissociative anesthetic, not a classical psychedelic like psilocybin. The subjective experiences can overlap, but the pharmacology is distinct.

Why is it different from SSRIs?+

SSRIs primarily modulate serotonin over weeks. Ketamine acts rapidly on the glutamate system and appears to influence synaptic plasticity through different molecular pathways.

What does 'neuroplasticity' actually mean here?+

Neuroplasticity describes the brain's ability to form and reorganize synaptic connections. Research suggests ketamine may transiently enhance this capacity, which could create a window for therapeutic work.

Does ketamine 'reset' the brain?+

No. 'Reset' is a popular metaphor, not a clinical description. Evidence points to changes in glutamate signaling and plasticity, not a wholesale reset.

What do patients typically experience during a session?+

Experiences vary. Common reports include altered perception, time distortion, emotional intensity, and a sense of detachment. Medical supervision is essential to manage these effects safely.

References

  1. Mechanisms of ketamine's antidepressant effects (review literature). National Institutes of Health
  2. Esketamine prescribing and program information. U.S. Food and Drug Administration

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.